Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection

N Hamajima1, K Matsuo, T Suzuki

  • 1Division of Epidemiology and Prevention, Aichi Cancer Center, Chikusa-ku, Nagoya 464-8681, Japan. nhamajim@aichi-cc.pref.aichi.jp

Insights

A myeloperoxidase (MPO) gene polymorphism, specifically the low-expression A allele, is associated with a reduced risk of persistent Helicobacter pylori (HP) infection, particularly in males and smokers. This suggests inflammation influences HP infection persistence.

Area of Science:

  • Genetics
  • Immunology
  • Gastroenterology

Background:

  • Interleukin-1 beta (IL-1B) gene polymorphism influences persistent Helicobacter pylori (HP) infection.
  • Myeloperoxidase (MPO) is an inflammation-related enzyme involved in immune responses.

Purpose of the Study:

  • To investigate the association between MPO gene polymorphism and HP infection prevalence.
  • To explore potential effect modification by smoking and milk intake on this association.

Main Methods:

  • Genotyping of MPO gene polymorphism (-463 G/A) in 241 non-cancer outpatients.
  • Identification of HP infection using High-molecular weight Campylobacter-Associated-Protein (HM-CAP) ELISA.
  • Statistical analysis including odds ratio (OR) calculation with confidence intervals (CI).

Main Results:

  • The low-expression MPO A allele showed a reduced odds ratio for HP infection, particularly in males (OR=0.31).
  • Significantly reduced ORs for HP infection were observed in current smokers (OR=0.19) and occasional/non-milk drinkers (OR=0.25) with the GA/AA genotypes.
  • Genotype frequencies were GG (79.7%), GA (19.5%), and AA (0.8%).

Conclusions:

  • MPO gene polymorphism may influence the susceptibility to persistent HP infection.
  • Inflammatory responses in gastric mucosa potentially play a role in HP infection persistence.
  • Smoking and milk intake may act as effect modifiers in the association between MPO polymorphism and HP infection.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...